OncLiveDLBCL Landscape Shifts Dramatically With Axicabtagene Ciloleucel FDA ApprovalOncLiveThe non–Hodgkin lymphoma landscape recently underwent a major transformation, as researchers in the field saw the FDA approval of axicabtagene ciloleucel (axi-ce… Continue reading
|
Second CAR–T Cell Therapy Approved by FDA
Lexology Less than two months after approving the first gene therapy for use in the U.S., that of Novartis’s Kymriah for treatment of pediatric patients with acute lymphoblastic leukemia (ALL)1, the FDA has approved a second single-infusion CAR–T cell therapy … |
OncLive |
Second CAR–T Cell Therapy Approved by FDA
Lexology Less than two months after approving the first gene therapy for use in the U.S., that of Novartis’s Kymriah for treatment of pediatric patients with acute lymphoblastic leukemia (ALL)1, the FDA has approved a second single-infusion CAR–T cell therapy … DLBCL Landscape Shifts Dramatically With Axicabtagene Ciloleucel FDA ApprovalOncLive |
Sports Illustrated |
Bryce Love, Stanford’s One-Man First Down
Sports Illustrated For a few days a week during the season and on weekdays during the summer, Love works in the laboratory of Michael Longaker, a surgeon who studies how stem cells might be used to help patients heal without scarring. Love does grunt work to aid Ph.D. |
|
EMT’s stem cell donation saves woman’s life
EMS1.com WAILUKU, Hawaii — An EMT is being credited with saving a cancer patient’s life after donating his stem cells. The Maui News reported that Wailuku EMT Wayne Segundo has never met the 39-year-old Australian woman, but already considers her family. |